Women's Health Coalition Canada’s Post

Today, the UK Women and Equalities Committee released a powerful report highlighting “medical misogyny” in healthcare. The report highlights the systemic biases that leave women undiagnosed for years, often enduring unnecessary pain from reproductive health conditions. As a company dedicated to advancing women’s health, we believe this report underscores the urgent need for change. Women’s health must be prioritised in clinical research, diagnostic pathways, and treatment access. By addressing these disparities, we can contribute to a future where no woman’s health concerns are minimised or overlooked. At Gedeon Richter, we’re committed to working alongside healthcare professionals, policymakers, and advocacy groups to close the gender health gap. Let’s collaborate to turn these findings into action. Read more about the report here: https://lnkd.in/eCmVTKYR #WomensHealth #HealthEquality #MedicalMisogyny #PharmaInnovation UK-GED-2400197 December 2024

Hertility, a pioneering reproductive health company, has secured over $14 million in funding, bolstered by esteemed investor Emma Watson. This significant investment underscores Watson's commitment to women-led initiatives and environmental activism. Hertility's innovative approach provides personalized testing and services, including diagnostic testing, egg freezing, and telemedicine, transforming women's reproductive health. Watson's involvement highlights the critical need for innovation in obstetrics and gynecology. Research indicates that every pound invested in these areas can yield £319 million for the economy, according to the British National Health Service. With influential backers like Watson, Hertility is poised to revolutionize reproductive wellness, addressing pressing women's health concerns. This funding milestone underscores the growing interest in women's health and empowers Hertility to drive meaningful change. #clickmepakistan #Hertility #ReproductiveHealth #EmmaWatson #WomenLed #HealthcareInnovation #WomenEmpowerment #HealthTech

🎙️ Join us for an insightful episode featuring Dr. Yemi Famuyiwa, a dedicated OB-GYN and fertility specialist from Montgomery Fertility Center in Rockville, Maryland. Dr. Famuyiwa shares her personal journey of balancing a demanding medical career with family planning. We explore the unique challenges female physicians face, including stigma and systemic barriers, and discuss practical strategies for navigating fertility preservation and family planning. Dr. Famuyiwa emphasizes the importance of normalizing discussions about fertility in medical education and advocates for supportive workplace policies. Whether you're a healthcare professional or simply interested in the intersection of career and family planning, this episode offers valuable insights and actionable strategies for creating a more inclusive healthcare environment. Key Takeaways: -Female physicians face unique challenges balancing careers and family planning. -Supportive workplace policies are crucial for managing these challenges. -Increased awareness and advocacy in medical institutions are needed. -Empowerment and informed reproductive health decisions are essential. -Mentorship and peer support are vital for overcoming related challenges. -Addressing societal stigmas is necessary for creating supportive environments. Tune in to gain a deeper understanding of how we can foster a healthier, more sustainable future for women in medicine. Listen now! https://lnkd.in/geaCiT9A Oluyemisi Famuyiwa MD, FACOG #FertilityAndCareer #WomenInMedicine #HealthcareAdvocacy #WorkLifeBalance #TheMentalHealthandWellnessShow #hwspodcast 🎧

#Womenshealthcare has been a big topic in the news and over the past few years. Terms like #medicalgaslighting and the #caregap have become more prominent as we as a society discuss how the health care system has let women down over and over again. What is the history of #obstetrics and #gynecology care? Learn more about it in my latest Substack post! https://lnkd.in/eE_ATXRE

AMWA leader, Dr. Gloria Bachmann, Professor of Obstetrics, Gynecology, and Reproductive Sciences and Associate Dean of Women's Health at the Robert Wood Johnson Medical School in NJ, represented our organization at a convening on Women and Aging, hosted by the White House Gender Policy Council and the White House Office of Public Engagement. The focus of this briefing was the economic disadvantages faced by as they age. The speakers highlighted the workplace inequities that persist throughout women’s lives due to a myriad of factors including: discrimination, occupational segregation, lack of employee benefits, and unpaid leave for caregiving. The accumulation of these challenges over the lifespan coupled with the fact that women typically live 17% longer than men lead to significant economic challenges. READ MORE: https://lnkd.in/gcRtKzR5

Dr. Charlotte Owens, MD, FACOG, Organon’s Head of Medical Affairs & Outcomes Research, spoke at the #FierceBiotechSummit on the topic of Empowering Women’s Health through Biotech Innovation and Research. The discussion focused on the impact investment in women’s health can have on society as a whole. Increasing awareness of women’s health, including and beyond sexual and reproductive health, can not only help women thrive but also help their families, communities, and economies. Our mini mic team met Dr. Owens afterwards to get her key takeaways. #WomensHealth #Biotech24 Fierce Life Sciences Events

Why do we encourage women to build non-profits? I love that the NHS is having this conversation, it's a step in the right direction but… It's disheartening to hear they want to only work with altruistic companies. I completely agree Flo selling data is despicable, don't understand how this is legal and this is the exact reason I deleted my free version of Flo and paid Clue. I am happy to pay for a good service, understand they are a for-profit company and hope they make a lot of money. The fact that it was co-founded by Ida Tin is an added bonus. Let's support female-led companies with our wallets (shoutout to Jesse Draper). This is why I believe we should be encouraging women to be ambitious and build the next Femtech unicorn! Encourage women to build highly profitable, ethical companies. And receive funding from the NHS to use these apps as diagnostic tools to better serve women. Lead the way in R&D and innovation. While I applaud the conversation that is happening, let's change the mentality that Femtech companies should be non-profits because this is one of the reasons they don't get funded. Investors want a return on investment, otherwise they'd be called donors. Another point addressed in the video is the lack of accessibility for some women to for-profit apps. Thanks to this video and the conversation stemming from it, companies could think of a sponsorship program. For example, I'd be happy to pay extra for a woman who cannot afford Clue. If 20 women paid +$2 on their annual membership, this would provide a free year for someone else. This is such a great step. Necessary conversations are being had, and great ideas will come of it. Well done ladies! Thank you Samantha Niblett MP for having this conversation.

Great to see this discussion happening in parliament!💪 FemTech apps have an amazing potential to improve women’s health outcomes, but a lack of regulation means they could also cause harm. In this interview published earlier this year in Femtech World I had a bit of a rant about how Femtech developers must work with clinicians and researchers from multiple disciplines to ensure their apps (1) improve the health of their users, and (2) can be used to conduct high quality research on women’s health. While I stand by this, since it was published, I’ve reflected (with the aid of Luana De Giorgio, who is incredibly insightful as always) on what’s driving the problem. In many cases, I don’t think it’s the femtech company themselves, but rather the investors who are putting profit before integrity. Similar to how many researchers are passionate about women’s health but hindered by a lack of research funding, I’ve met femtech innovators who are driven to improve health (in an evidenced based way) but also struggle to find investment. As is often the case, it all comes down to 💷 💷 💷. My argument is the same. Let’s work together - researchers and femtech developers - to ensure apps are helping rather than exploiting women. There are dedicated funds available for industry-academia partnerships. Academics are skilled grant writers. Partnering with universities is a cost effective way for femtech companies to draw on world class research expertise. And researchers can co-design data collection protocols and gain access to valuable data resources on large samples for impactful research. If you’re a femtech developer interested in working with academic researchers, get in touch. Through the 4M: Menarche, Menstruation, Menopause & Mental Health, I can connect you to a network of over 350 women’s health researchers 😃 https://lnkd.in/eqrZNSa9

**Advocating for Better Women's Health Policies: A Call to Action** As a General Practitioner with a specialization in Obstetrics and Gynecology, I've witnessed firsthand the profound impact that effective healthcare policies can have on women's health. However, there is still much work to be done to ensure that all women have access to the care they need. One pressing issue is the disparity in access to comprehensive reproductive healthcare. Despite advancements, many women still face barriers to obtaining essential services such as prenatal care, contraception, and screenings for conditions like cervical cancer. These barriers are often amplified for women in underserved communities. It's crucial that we advocate for policies that: 1. **Increase Access to Care**: Support initiatives that expand healthcare coverage and make reproductive health services accessible and affordable for all women, regardless of their socio-economic status. 2. **Promote Preventative Care**: Emphasize the importance of preventative care, encouraging regular screenings and check-ups to catch potential health issues early. 3. **Support Maternal Health**: Enhance support for maternal health, including mental health resources for expectant and new mothers, to reduce maternal mortality and improve outcomes for both mothers and babies. 4. **Address Health Disparities**: Push for research and policies that specifically address health disparities affecting women of color and those in rural areas, ensuring equity in healthcare delivery. By working together, healthcare professionals, policymakers, and advocates can create a more equitable healthcare system. I urge my colleagues and network to engage with local representatives, support relevant initiatives, and raise awareness about these critical issues. Let's continue to advocate for policies that prioritize women's health and ensure that every woman has the opportunity to live a healthy, fulfilling life. #WomensHealth #HealthcareAdvocacy #PolicyChange #ReproductiveHealth #MaternalHealth #HealthEquity

Introduction by Croakey: In responding to the recent Federal Budget, the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) welcomed a range of investments in women’s health, including funding for chronic pelvic pain conditions, a review of Medical Benefits Schedule items to address gender-bias within the healthcare system, and training for rural and remote healthcare professionals on the insertion and removal of long-acting reversible contraceptives. The College also welcomed investments in the extension of sexual and reproductive telehealth items to support women accessing affordable abortion services, especially those in rural and remote areas, and investments in health and medical research, with women’s health identified as one of three key priority areas eligible to receive more funding for new research. The budget also pledged $12.5 million for free menstrual products in Aboriginal and Torres Strait Islander communities. In the article below, first published by The Conversation, Associate Professor Nina Lansbury and Minnie King, from the School of Public Health at the University of Queensland, explain the significance of this investment, and also why further action is needed to ensure menstrual health equity, or ‘period parity’ (terms that are preferred to ‘period poverty’, according to this cited reference).